Cell BiologybioRxivPreprint
PARP16 protects against pathological cardiac remodelling by ADP-ribosylation-dependent inhibition of NFAT transcription factor
Sima Zarinfard, Sukanya Raghu, Arathi Bangalore Prabhashankar…·Nagalingam Ravi Sundaresan
This study shows PARP16 reduces cardiac remodelling by inhibiting NFAT transcription through ADP-ribosylation, with implications for heart failure treatment.